<font color="red">Effect_1</font> of <font color="red">rosuvastatin_1</font> <font color="red">monotherapy_1</font> or <font color="red">in_1</font> <font color="red">combination_1</font> <font color="red">with_1</font> <font color="red">fenofibrate_1</font> or <font color="red">ω-3_1</font> <font color="red">fatty_1</font> <font color="red">acids_1</font> on <font color="red">lipoprotein_2</font> <font color="red">subfraction_2</font> <font color="red">profile_2</font> <font color="red">in_1</font> <font color="red">patients_1</font> <font color="red">with_2</font> <font color="red">mixed_2</font> <font color="red">dyslipidaemia_2</font> <font color="red">and_1</font> <font color="red">metabolic_2</font> <font color="red">syndrome_2</font> <font color="red">._2</font> <font color="red">
<br>
<br>_1</font> BACKGROUND <font color="red">Raised_1</font> <font color="red">triglycerides_1</font> <font color="red">(_1</font> <font color="red">TG_1</font> <font color="red">)_1</font> , <font color="red">decreased_1</font> <font color="red">high_2</font> <font color="red">-_2</font> <font color="red">density_2</font> <font color="red">lipoprotein_2</font> <font color="red">cholesterol_2</font> <font color="red">(_2</font> <font color="red">HDL_2</font> <font color="red">-_2</font> <font color="red">C_2</font> <font color="red">)_2</font> <font color="red">levels_2</font> and <font color="red">a_1</font> <font color="red">predominance_1</font> <font color="red">of_1</font> <font color="red">small_1</font> <font color="red">dense_1</font> <font color="red">low_1</font> <font color="red">density_1</font> <font color="red">lipoproteins_1</font> <font color="red">(_1</font> <font color="red">sdLDL_1</font> <font color="red">)_1</font> are <font color="red">characteristics_1</font> of <font color="red">the_1</font> <font color="red">metabolic_2</font> <font color="red">syndrome_2</font> <font color="red">(_2</font> <font color="red">MetS_2</font> <font color="red">)_2</font> <font color="red">._2</font> <font color="red">
<br>_1</font> OBJECTIVE <font color="red">To_1</font> <font color="red">compare_1</font> <font color="red">the_1</font> <font color="red">effect_1</font> <font color="red">of_1</font> <font color="red">high_1</font> <font color="red">-_1</font> <font color="red">dose_1</font> <font color="red">rosuvastatin_1</font> <font color="red">monotherapy_1</font> <font color="red">with_1</font> <font color="red">moderate_1</font> <font color="red">dosing_1</font> combined <font color="red">with_1</font> <font color="red">fenofibrate_1</font> or <font color="red">ω-3_1</font> <font color="red">fatty_1</font> <font color="red">acids_1</font> <font color="red">on_1</font> <font color="red">the_1</font> <font color="red">lipoprotein_2</font> <font color="red">subfraction_2</font> <font color="red">profile_2</font> <font color="red">in_1</font> <font color="red">patients_1</font> <font color="red">with_2</font> <font color="red">mixed_2</font> <font color="red">dyslipidaemia_3</font> <font color="red">and_2</font> <font color="red">MetS._3</font> 
<br> METHODS We previously randomised patients with <font color="red">low_2</font> <font color="red">-_2</font> <font color="red">density_2</font> <font color="red">lipoprotein_2</font> <font color="red">cholesterol_2</font> <font color="red">(_2</font> <font color="red">LDL_2</font> <font color="red">-_2</font> <font color="red">C_2</font> <font color="red">)_2</font> > 160 and TG > 200   mg / dl to <font color="red">rosuvastatin_1</font> <font color="red">monotherapy_1</font> 40   mg / day ( R group , n = 30 ) or <font color="red">rosuvastatin_1</font> 10 mg / day <font color="red">combined_1</font> <font color="red">with_1</font> <font color="red">fenofibrate_1</font> 200 mg / day ( RF group , n = 30 ) <font color="red">or_1</font> <font color="red">ω-3_1</font> <font color="red">fatty_1</font> <font color="red">acids_1</font> 2 g / day ( Rω group , n = 30 ) . In the <font color="red">present_1</font> <font color="red">study_1</font> <font color="red">,_1</font> <font color="red">only_1</font> <font color="red">patients_1</font> <font color="red">with_1</font> <font color="red">MetS_2</font> <font color="red">were_1</font> <font color="red">included_1</font> ( 24 , 23 and 24 in the R , RF and Rω groups respectively ) . <font color="red">At_1</font> <font color="red">baseline_1</font> and <font color="red">after_1</font> <font color="red">12_1</font> <font color="red">weeks_1</font> <font color="red">of_1</font> <font color="red">treatment_1</font> <font color="red">,_1</font> <font color="red">the_1</font> <font color="red">lipoprotein_2</font> <font color="red">subfraction_2</font> <font color="red">profile_2</font> <font color="red">was_1</font> <font color="red">determined_2</font> <font color="red">by_2</font> <font color="red">polyacrylamide_2</font> <font color="red">3%_2</font> <font color="red">gel_2</font> <font color="red">electrophoresis_2</font> <font color="red">._2</font> 
<br> RESULTS <font color="red">The_1</font> <font color="red">mean_4</font> <font color="red">LDL_4</font> <font color="red">size_4</font> <font color="red">was_1</font> <font color="red">significantly_1</font> <font color="red">increased_2</font> <font color="red">in_1</font> <font color="red">all_1</font> <font color="red">groups_1</font> <font color="red">._1</font> <font color="red">This_1</font> <font color="red">change_1</font> <font color="red">was_1</font> <font color="red">more_1</font> <font color="red">prominent_1</font> <font color="red">with_1</font> <font color="red">RF_1</font> than <font color="red">with_1</font> <font color="red">other_1</font> <font color="red">treatments_1</font> <font color="red">in_1</font> <font color="red">parallel_1</font> with <font color="red">its_1</font> <font color="red">greater_1</font> <font color="red">hypotriglyceridemic_2</font> <font color="red">capacity_2</font> ( p < 0.05 <font color="red">compared_1</font> <font color="red">with_1</font> <font color="red">R_1</font> <font color="red">and_1</font> <font color="red">Rω_1</font> <font color="red">)_1</font> . A <font color="red">decrease_3</font> <font color="red">in_3</font> <font color="red">insulin_5</font> <font color="red">resistance_5</font> <font color="red">by_3</font> <font color="red">RF_3</font> was <font color="red">also_1</font> <font color="red">noted_1</font> <font color="red">._1</font> <font color="red">Only_1</font> <font color="red">RF_1</font> <font color="red">significantly_1</font> <font color="red">raised_1</font> <font color="red">HDL_4</font> <font color="red">-_4</font> <font color="red">C_4</font> <font color="red">levels_4</font> ( by 7.7% , p < 0.05 ) <font color="red">by_1</font> <font color="red">increasing_1</font> <font color="red">the_1</font> <font color="red">cholesterol_2</font> <font color="red">of_2</font> <font color="red">small_2</font> <font color="red">HDL_2</font> <font color="red">particles_2</font> <font color="red">._2</font> <font color="red">The_1</font> <font color="red">cholesterol_3</font> <font color="red">of_3</font> <font color="red">larger_4</font> <font color="red">HDL_4</font> <font color="red">subclasses_4</font> <font color="red">was_1</font> <font color="red">significantly_1</font> <font color="red">increased_2</font> <font color="red">by_1</font> <font color="red">R_1</font> <font color="red">and_1</font> <font color="red">Rω._1</font> 
<br> CONCLUSIONS <font color="red">All_1</font> <font color="red">regimens_1</font> <font color="red">increased_1</font> <font color="red">mean_3</font> <font color="red">LDL_3</font> <font color="red">size_3</font> <font color="red">;_3</font> <font color="red">RF_1</font> <font color="red">was_1</font> <font color="red">the_1</font> <font color="red">most_1</font> <font color="red">effective_1</font> <font color="red">._1</font> <font color="red">A_1</font> <font color="red">differential_1</font> <font color="red">effect_1</font> <font color="red">of_1</font> <font color="red">treatments_1</font> <font color="red">was_1</font> <font color="red">noted_1</font> on <font color="red">the_1</font> <font color="red">HDL_2</font> <font color="red">subfraction_2</font> <font color="red">profile_1</font> <font color="red">._1</font>